GSK
839 hedge funds and large institutions have $12.4B invested in GSK in 2020 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 270 increasing their positions, 320 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.12% less ownership
Funds ownership: 5% → 4.87% (-0.12%)
16% less repeat investments, than reductions
Existing positions increased: 270 | Existing positions reduced: 320
25% less funds holding in top 10
Funds holding in top 10: 16 → 12 (-4)
Holders
839
Holding in Top 10
12
Calls
$94.9M
Puts
$71.7M
Top Buyers
| 1 | +$189M | |
| 2 | +$166M | |
| 3 | +$84.6M | |
| 4 |
Two Sigma Advisers
New York
|
+$82.7M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$51.3M |
Top Sellers
| 1 | -$171M | |
| 2 | -$158M | |
| 3 | -$103M | |
| 4 |
Dodge & Cox
San Francisco,
California
|
-$103M |
| 5 |
Morgan Stanley
New York
|
-$49.2M |